Skip to main content
Neha Panchal

Neha Panchal

Regulatory Strategy & Affairs Consultant | Global Submissions | Health Authority Interactions | Lifecycle Management

Talent
CoquitlamMember since July 9, 2026
Global Regulatory StrategyHealth Authority InteractionsScientific Advice Briefing PackagesPost-Approval VariationsRegulatory Risk AssessmentLifecycle ManagementGMP Quality Assurance
·

Hire this person

Send a job offer directly to this candidate

Global Regulatory StrategyHealth Authority InteractionsScientific Advice Briefing PackagesPost-Approval VariationsRegulatory Risk Assessment

About

Regulatory Affairs Consultant specialising in global submission strategy, Health Authority (HA) interactions, and development-stage regulatory planning across EU, UK, US, Latin America, and Asia Pacific markets. Proven track record achieving deficiency-free approvals in 10+ countries, with direct agency engagement including COFEPRIS Mexico and Ministerio de Salud Costa Rica. Experienced in end-to-end CTA and MAA preparation, IMPD and Investigator Brochure authoring, scientific advice briefing packages, pre-IND meeting preparation, and post-approval lifecycle management.

Brings first-hand understanding of regulatory pathways in markets where access defines success, directly aligned with missions advancing medicines for underserved populations. MBA-qualified with a focus on sustainable pharmaceutical market development. Active member of TOPRA and RAPS.

Experience

Drug Regulatory Affairs Consultant (Freelance) at Self-Employed (2025-05 – Present)

Therapeutic Areas: Oncology | Haematology

  • Developed and led global regulatory strategy for CTA, MAA, and ANDA submissions across EU, UK, and Asia, including submission roadmaps, regulatory risk assessments, and proactive gap identification to optimise development timelines.
  • Managed Health Authority interactions and prepared high-quality briefing documentation for scientific advice and pre-submission meetings, ensuring alignment of clinical and regulatory positions prior to submission.
  • Authored and reviewed IMPD, Investigator Brochures, clinical study protocols, and protocol amendments in collaboration with Clinical Operations and Medical Writing teams, ensuring ICH GCP and regulatory compliance.
  • Produced EMA QRD, FDA PLR, and regionally-adapted labelling (SmPC, PIL, PI), maintaining CCDS version control and multi-country localisation through eCTD systems.
  • Coordinated post-approval variations and lifecycle updates, tracking implementation timelines across jurisdictions and responding to HA queries to maintain ongoing compliance.
  • Supported inspection readiness at client manufacturing sites by maintaining comprehensive regulatory documentation and activity records aligned with WHO-GMP standards.

Drug Regulatory Affairs Executive at Concord Biotech Ltd. (2021-10 – 2022-12)

Therapeutic Areas: Immunology | Immunosuppressants (Transplant Medicine)

  • Designed and executed end-to-end regulatory strategy for niche immunosuppressant products (Tacrolimus, Mycophenolate Mofetil, Mycophenolate Sodium) across 10+ countries in Latin America and MENA, including agency landscape analysis and submission sequencing for optimal market entry.
  • Led CTD, eCTD, and ACTD dossier preparation and submissions, including US FDA-aligned dossiers; managed pre- and post-approval query responses with COFEPRIS Mexico, Ministerio de Salud Costa Rica, and other regional health authorities.
  • Prepared HA interaction packages including regulatory briefing documents; led and co-led face-to-face and written meetings with local regulatory agencies to resolve queries and facilitate approvals.
  • Managed post-approval change variations and lifecycle updates across multiple dossiers, ensuring continuous compliance throughout the product lifecycle.
  • Authored SmPCs, PILs, and prescribing information aligned with latest CCDS and regional templates; managed version control through eCTD systems.
  • Developed labelling matrices to monitor regulatory implementation timelines; delivered regulatory intelligence to marketing teams to inform product positioning and launch strategy.

Quality Assurance Officer at Elite Pharma Pvt Ltd. (2020-02 – 2021-10)

Therapeutic Areas: OTC | CNS / Psychiatry | Neurology

  • Executed GMP quality assurance for oral solid and liquid dosage form manufacturing; implemented and maintained SOPs and continuous process improvements.
  • Managed CAPAs in response to quality deviations, conducting root cause analysis and implementing corrective measures to maintain product quality and regulatory compliance.
  • Led WHO-GMP compliance submissions and validation/calibration activities; maintained comprehensive regulatory documentation for internal and external stakeholders.

Education

MBA in Sustainability in Pharmaceuticals – Leeds Beckett University (2023-01 – 2024-11)

M.Pharm in Pharmaceutical Quality Assurance – Gujarat Technological University (2021-12)

B.Pharm – Gujarat Technological University (2019-12)

Skills

Regulatory Strategy & Affairs ConsultantGlobal SubmissionsHealth Authority InteractionsLifecycle Management

Reviews